FDA approves Kura and Kyowa Kirin’s drug for form of acute myeloid leukemianews2025-11-13T19:58:31+00:00November 13th, 2025|Endpoints News|
UK gives drugmakers third extension to opt out of medicine rebate schemenews2025-11-13T18:39:59+00:00November 13th, 2025|Endpoints News|
Pfizer closes up to $10B deal for obesity biotech Metseranews2025-11-13T17:51:38+00:00November 13th, 2025|Endpoints News|
AbbVie, Alphabet’s Calico end 11-year partnership in aging researchnews2025-11-13T16:09:58+00:00November 13th, 2025|Endpoints News|
Abeona’s skin disease cell therapy launch stymied by false-positive sterility testnews2025-11-13T15:43:19+00:00November 13th, 2025|Endpoints News|
Merck KGaA still in tariff talks with the White House, weeks after deal was announced news2025-11-13T14:29:36+00:00November 13th, 2025|Endpoints News|
Q&A: Bausch + Lomb CEO Brent Saunders on turnaround, AI, TrumpRxnews2025-11-13T12:00:49+00:00November 13th, 2025|Endpoints News|
Pazdur vs. Prasad: Can the CDER-CBER dynamic change under new leadership?news2025-11-12T20:37:57+00:00November 12th, 2025|Endpoints News|
Lilly drops CVS as drug benefits manager — reportnews2025-11-12T20:08:40+00:00November 12th, 2025|Endpoints News|
Chinese biotechs are shedding their fast-follower reputations as innovation surgesnews2025-11-12T18:18:10+00:00November 12th, 2025|Endpoints News|
